Clinical Trials on Dermatologic Disorders

Total 147451 results

Sohag University

Not yet recruiting

Prevelance Of Cutaneous Disorders Among Patients With Heamatologic Malignancies

Dermatologic Disorders With Heamatologic Malignancies Patients

Egypt
University of Vienna
Medical University of Vienna

Completed

Confocal Raman Spectroscopy: in Vivo Measurement of Physiological Skin Parameters

Dermatologic Disorders | Disorder of Cholesterol Metabolism
Sciton

Completed

Pilot Evaluation of Thulium Laser Alone or in Combination With Broad Band Light for Treatment of Dermatologic Conditions

Dermatology/Skin - Other

United States
Yonsei University

Unknown

Prospective and Retrospective Cohort Study to Find New Prognostic Factors and Therapeutic Targets in Patients With Newly Diagnosed or Relapsed Malignant Hematologic Disorder Excluding Acute Leukemia

Malignant Hematologic Disorder

Korea, Republic of
Medical University of Graz
Joanneum Research Forschungsgesellschaft mbH

Completed

Bioequivalence of Topical Acyclovir in Healthy Volunteers (FDA_BE1)

Dermatologic Disorders

Austria
Northwestern University

Completed

Use of Alternative Medicine Among Outpatients in Dermatology and Primary Care Clinics

Dermatologic Disorders

United States
Chinese University of Hong Kong

Completed

Cognitive-behavioural Intervention for Anxiety, Depression and Quality of Life Among Children Receiving Chemotherapy.

Depression | Quality of Life | Anxiety | Hematologic Malignancy

Ethiopia
Pusan National University Hospital

Completed

Assessment of Needs of Moisturizers After Various Laser Treatments

Dermatologic Disorders | Injury Due to Laser

Korea, Republic of
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Recruiting

Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases

Hematopoietic and Lymphoid Cell Neoplasm | Non-Neoplastic Hematologic and Lymphocytic Disorder

United States
St. Justine's Hospital

Not yet recruiting

Fertility Preservation With Ovarian Tissue Freezing (PTO)

Cancer | Infertility | Ovarian Failure | Hematologic Disorder

Canada
Memorial Sloan Kettering Cancer Center

Terminated

TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors

Non-Malignant Hematologic Disorders

United States
Memorial Sloan Kettering Cancer Center
Astellas Pharma US, Inc.

Completed

Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)

Hematologic Malignancy | Myeloproliferative Disorder

United States
University of Sheffield

Completed

Investigating Compassion-Based Guided Self-Help for Depression in People With Skin Conditions

Depression | Dermatologic Disease

United Kingdom
The First Affiliated Hospital of Soochow University

Recruiting

Avatrombopag to Promote Platelet Engraftment After Allo-HSCT

Platelet Disorder

China
Stemedica Cell Technologies, Inc.

Active, not recruiting

Safety Study of Bone Marrow Derived Stem Cells on Patients With Cutaneous Photoaging

Dermatologic Disorders | Chronic Effect of Ultraviolet Radiation on Photoaged Skin

United States
M.D. Anderson Cancer Center

Completed

Dexamethasone Dyspnea Study

Solid Tumors | Advanced Cancers | Hematologic Disorder

United States
UNC Lineberger Comprehensive Cancer Center

Terminated

Intervention to Address Psychosocial Needs Among Socially Disadvantaged Older Adults With Cancer

Hematological Disorder

United States
University Hospital, Geneva

Completed

Ex-Vivo Reversion of Platelet Inhibition Induced by Prasugrel

Acquired Platelet Disorder

Switzerland
Ayman Saad
Sobi, Inc.

Withdrawn

Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant

Platelet Disorder
Institut National de la Santé Et de la Recherche...

Enrolling by invitation

Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) (CATCH)

Thrombocytopenia | Inherited Platelet Disorder

France
M.D. Anderson Cancer Center

Not yet recruiting

Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder

Familial Platelet Disorder | Hematopoietic

United States
IRCCS Policlinico S. Matteo

Completed

Eltrombopag for Inherited Thrombocytopenias

Inherited Platelet Disorder

Italy
Region Stockholm
Karolinska Institutet

Recruiting

Towards Improved Diagnostics for Suspected Platelet Function Disorders

Platelet Disorder | Thrombocytopathy | Platelet Function Disorder

Sweden
Hospices Civils de Lyon

Completed

CAncer, NUtrition and Taste - Validation of the CANUT-QVA Questionnaire on Eating Habits in Cancer Patients (CANUT-QVA)

Chemotherapy Effect | Taste Disorders | Olfactory Disorder | Undernutrition | Hematologic Cancer | Chemotherapy-Induced Change

France
University Hospital, Angers

Unknown

Activates Charcoal for Patients Undergoing Invasive Procedure Delayed Due to Direct Oral Anticoagulants (CACAOD)

Anticoagulants; Circulating, Hemorrhagic Disorder

France
Vlad Radulescu

Completed

Ovarian Tissue Freezing For Fertility Preservation In Women Facing A Fertility Threatening Medical Diagnosis/Treatment

Cancer | Infertility | Rheumatologic Disorder | Hematologic Disorder

United States
Fred Hutchinson Cancer Center

Recruiting

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders

Non-Neoplastic Hematologic and Lymphocytic Disorder

United States
University of Zurich

Completed

Prevalence and Subjective Impairment of Quality of Life (QoL) Due to Dermatologic Diseases in Internal Medicine Patients

Dermatologic Disease of Inpatients in Internal Medicine

Switzerland
Celgene

Active, not recruiting

A Study to Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects With Hematological Disorders

Neoplasms | Hematologic Malignancies | Hematologic Neoplasm

United Kingdom, United States
University of Colorado, Denver

Recruiting

Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant for Treatment of High-risk Hematologic Disorders

Hematologic Disorders

United States
St. Jude Children's Research Hospital

Completed

Catheter Resistance Monitoring to Predict Catheter-Associated Adverse Events in Children and Adolescents

Cancer | Hematologic Disorders

United States
Sofia Ramström

Enrolling by invitation

Function of Platelets Used for Transfusions

Thrombocytopenia | Hematologic Malignancy

Sweden
M.D. Anderson Cancer Center
Celgene Corporation

Terminated

Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)

Hematologic Disorder

United States
Duke University

Recruiting

Survivorship Post-HCT Optimization Program (S-POP)

Hematologic Malignancy

United States
University of Arkansas
University of Iowa

Not yet recruiting

High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders

Plasma Cell Disorder
Chimagen Biosciences, Ltd

Recruiting

First-in-Human (FIH) Trial of 1A46 in Subjects With Advanced CD20 and/or CD19 Positive B-cell Hematologic Malignancies

Non-Hodgkin's Lymphoma (Disorder) | Acute Lymphoid Leukemia, Disease (Disorder)

United States
Baylor College of Medicine

Completed

Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders

Oncologic Disorders | Hematologic Disorders | Rheumatologic Disorders

United States
Institut Paoli-Calmettes

Unknown

An Evaluation of Patients Access to Their Electronic Medical Records Via the IPC Connect Application (ADN-CO)

Solid Tumor | Hematologic Malignancy
University of Alabama at Birmingham
National Cancer Institute (NCI)

Recruiting

Diet and Cognitive Training in Hematologic Cancer Survivors

Cognitive Impairment | Hematologic Malignancy

United States
Community Cancer Care
Amgen

Unknown

Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes

Cancer | Solid Tumor | Hematologic Malignancy

United States
M.D. Anderson Cancer Center

Withdrawn

Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic Disorders

Stem Cell Transplantation

United States
University of Oklahoma

Completed

Impact of Palliative Transfusions on Quality of Life in Patients With Blood Cancers on Hospice (PalliaQOL)

Hematologic Malignancy

United States
Massachusetts General Hospital

Terminated

Radiation Post-CAR T in Refractory Lymphoma

Refractory Lymphoma | Hematologic Malignancy

United States
Celgene

Completed

Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer

Hematologic Malignancy | Malignant Lymphoma

United States, United Kingdom
Celgene

Completed

Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer

Hematologic Malignancy | Malignant Lymphoma

United States, United Kingdom
Ciusss de L'Est de l'Île de Montréal
Celgene; C3i Center Inc.

Active, not recruiting

Len/Dex/DLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell Transplant

Multiple Myeloma | Relapsed Hematologic Malignancy

Canada
Pack Health
GlaxoSmithKline; University of Washington

Recruiting

PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma

Multiple Myeloma | Relapsed Hematologic Malignancy

United States
The First Affiliated Hospital of Soochow University

Unknown

Hemostatic Complications in Hematopoietic Stem Cell Transplantation (HCIHSCT)

Hemostatic Disorders

China
VarmX B.V.

Recruiting

Single Dose Trial of VMX-C001 in Healthy Subjects With and Without FXa Direct Oral Anticoagulant

Coagulation Disorder

Netherlands
HemoSonics LLC

Completed

QStat Pilot Reference Range Study

Coagulation Disorder

United States

Clinical Trials on Dermatologic Disorders

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations